Organogenesis Statistics
NASDAQ: ORGOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.29+0.01 (+0.78%)
Market open · Delayed 15 min · as of Oct 9, 2:00 PM ET
Organogenesis by the numbers
Organogenesis has a market capitalization of $166.0 million based on 128.67M shares outstanding. With trailing EPS of $-0.83, Organogenesis is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 23.1% below its 50-day average and 51.7% below its 200-day average.
Average daily trading volume is 779.50K shares, or about $1.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ORGO valuation vs. peer median
| Metric | ORGO | Peer median | Difference |
|---|---|---|---|
| Market cap | $165.99M | $162.21M | +2% |
| Avg. volume | 779.50K | 311.60K | +150% |
Peer median across 8 companies: NBP, EMIS, NKTX, ANTX, ALXO, MENS, MSLE, CNTN.
Valuation
- Market cap
- $165.99M
- EPS (TTM)
- $-0.83
- Shares outstanding
- 128.67M
Price and trading
- Previous close
- 1.28
- Open
- 1.28
- Day range
- 1.27 – 1.31
- 52-week range
- 1.25 – 7.08
- 52-week change
- -69.01%
- Beta
- —
- Volume
- 172.98K
- Average volume
- 779.50K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 165.99M
- Forward Pe
- -4.16
- Eps
- -0.83
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 7.08
- Week52 Low
- 1.25
- Avg Volume
- 779.50K
- Shares Outstanding
- 128.67M
- Ma50
- 1.68
- Ma200
- 2.67
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -81.77%
- Pct From52w Low
- 3.20%